The efficacy and safety of PD-1 inhibitors for EGFR-mutant non-small cell lung cancer after tyrosine kinase inhibitor failure: a retrospective real-world cohort study
@article{ATM109630, author = {Chunyang Zhou and Zijian Wang and Chengrui Fu and Hengmin Tao and Chengxin Liu}, title = {The efficacy and safety of PD-1 inhibitors for EGFR-mutant non-small cell lung cancer after tyrosine kinase inhibitor failure: a retrospective real-world cohort study}, journal = {Annals of Translational Medicine}, volume = {11}, number = {3}, year = {2023}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/109630} }